The use of artificial intelligence across biopharma and life science tools and services is developing quickly. Will A.I. become a major disruptive technology in healthcare with the potential to significantly enhance productivity, reduce time spent in drug discovery, and optimize manufacturing processes? Sel Hardy says that the implementation could positively impact revenue growth and margin expansion in the long run.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - schwabnetwork....
Download the iOS app - apps.apple.com...
Download the Amazon Fire Tv App - www.amazon.com...
Watch on Sling - watch.sling.co...
Watch on Vizio - www.vizio.com/...
Watch on DistroTV - www.distro.tv/...
Follow us on X - / schwabnetwork
Follow us on Facebook - / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - schwabnetwork....
#stocks #ai #healthcare #biopharma #investing #trading #stockmarket #wallstreet #money #finance #businessnews #news
Негізгі бет A.I. Impact On Biopharma: LLY, AMGN, TMO, CRL
Пікірлер: 3